• 1. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 2. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 3. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 4. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 5. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860

tert-butyl N-[(1S,2S)-2-hydroxycyclopentyl]carbamate: A Comprehensive Overview

The compound with CAS No. 145106-43-0, commonly referred to as tert-butyl N-[(1S,2S)-2-hydroxycyclopentyl]carbamate, is a significant molecule in the field of organic chemistry and pharmacology. This compound has garnered attention due to its unique structural properties and potential applications in drug development and material science. The tert-butyl group attached to the molecule contributes to its stability and lipophilicity, while the cyclopentyl ring introduces rigidity and stereochemical complexity. The hydroxyl group present in the structure plays a crucial role in hydrogen bonding, which is essential for its interactions with biological systems.

Recent studies have highlighted the importance of stereochemistry in the design of bioactive compounds. The (1S,2S) configuration of the cyclopentane ring in tert-butyl N-[(1S,2S)-2-hydroxycyclopentyl]carbamate is particularly interesting, as it influences the molecule's pharmacokinetic properties and bioavailability. Researchers have employed advanced computational methods, such as molecular docking and quantum mechanics, to explore how this configuration affects the molecule's binding affinity to target proteins. These findings suggest that the stereochemistry of the compound could be optimized to enhance its therapeutic potential.

The synthesis of tert-butyl N-[(1S,2S)-2-hydroxycyclopentyl]carbamate involves a multi-step process that combines principles from both organic synthesis and asymmetric catalysis. The use of chiral catalysts has been pivotal in achieving the desired stereochemical outcome during the formation of the cyclopentane ring. This approach not only ensures high enantiomeric excess but also aligns with green chemistry principles by minimizing waste and reducing energy consumption.

In terms of applications, tert-butyl N-[(1S,2S)-2-hydroxycyclopentyl]carbamate has shown promise in several therapeutic areas. Preclinical studies have demonstrated its potential as an anti-inflammatory agent, where its ability to modulate key inflammatory pathways has been extensively investigated. Additionally, this compound has been explored as a candidate for treating neurodegenerative diseases due to its neuroprotective properties. Recent research has also delved into its role as a building block for more complex molecules with enhanced bioactivity.

The integration of cutting-edge analytical techniques has furthered our understanding of this compound's properties. For instance, nuclear magnetic resonance (NMR) spectroscopy has provided insights into its conformational flexibility, while mass spectrometry has been instrumental in confirming its molecular weight and structural integrity. These advancements have not only validated the compound's identity but also paved the way for its use in more sophisticated experiments.

Looking ahead, the future of tert-butyl N-[(1S,2S)-2-hydroxycyclopentyl]carbamate lies in its potential to serve as a lead compound for drug discovery programs. Collaborative efforts between academia and industry are expected to accelerate its development into a clinically relevant therapeutic agent. Moreover, ongoing research into its biodegradation pathways will be crucial for ensuring its environmental safety and sustainability.

In conclusion, tert-butyl N-[(1S,2S)-2-hydroxycyclopentyl]carbamate represents a fascinating intersection of chemistry and biology. Its unique structure, coupled with advancements in synthetic methodology and analytical techniques, positions it as a valuable tool in both academic research and industrial applications. As our understanding of this compound continues to grow, so too does its potential to make meaningful contributions to the field of medicinal chemistry.

• 481073-50-1(Carbamic acid, [(1R,2R,3S)-2,3-dihydroxycyclopentyl]-, 1,1-dimethylethyl ester,)
• 155837-14-2(tert-butyl ((1R,2R)-2-Hydroxycyclopentyl)carbamate)
• 291533-28-3(tert-butyl N-[(1R,2S)-2-hydroxycyclohexyl]carbamate)
• 121282-70-0(tert-butyl N-[trans-2-hydroxycyclohexyl]carbamate)
• 145166-06-9(tert-butyl N-[(1S,2S)-2-hydroxycyclohexyl]carbamate)
• 214679-17-1(tert-butyl N-[(1S,2R)-2-hydroxycyclohexyl]carbamate)
• 155837-16-4(tert-butyl N-[cis-2-hydroxycyclopentyl]carbamate)
• 155975-19-2(tert-butyl N-[(1R,2R)-2-hydroxycyclohexyl]carbamate)
• 599207-03-1(Carbamic acid, [(1S)-1-[(1R)-1-hydroxyethyl]butyl]-, 1,1-dimethylethyl ester)
• 454170-16-2(tert-butyl N-[(1R,2R)-2-hydroxycyclopentyl]carbamate)